Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

Structural brain signature of cognitive decline in Parkinson's disease: DTI-based evidence from the LANDSCAPE study.

Gorges M, Müller HP, Liepelt-Scarfone I, Storch A, Dodel R; LANDSCAPE Consortium, Hilker-Roggendorf R, Berg D, Kunz MS, Kalbe E, Baudrexel S, Kassubek J.

Ther Adv Neurol Disord. 2019 May 16;12:1756286419843447. doi: 10.1177/1756286419843447. eCollection 2019.

PMID:
31205489
2.

No association between Parkinson disease and autoantibodies against NMDA-type glutamate receptors.

Hopfner F, Müller SH, Steppat D, Miller J, Schmidt N, Wandinger KP, Leypoldt F, Berg D, Franke A, Lieb W, Tittmann L, Balzer-Geldsetzer M, Baudrexel S, Dodel R, Hilker-Roggendorf R, Kalbe E, Kassubek J, Klockgether T, Liepelt-Scarfone I, Mollenhauer B, Neuser P, Reetz K, Riedel O, Schulte C, Schulz JB, Spottke A, Storch A, Trenkwalder C, Wittchen HU, Witt K, Wüllner U, Deuschl G, Kuhlenbäumer G.

Transl Neurodegener. 2019 Apr 3;8:11. doi: 10.1186/s40035-019-0153-0. eCollection 2019.

3.

Cytotoxic edema affecting distinct fiber tracts in ciguatera fish poisoning.

Yalachkov Y, Hildner M, Polomac N, Jahnke K, Wagner M, Baudrexel S.

Neurology. 2019 Jan 15;92(3):145-147. doi: 10.1212/WNL.0000000000006789. Epub 2018 Dec 21. No abstract available.

PMID:
30578371
4.

Cognitive decline in Parkinson's disease: the impact of the motor phenotype on cognition.

Wojtala J, Heber IA, Neuser P, Heller J, Kalbe E, Rehberg SP, Storch A, Linse K, Schneider C, Gräber S, Berg D, Dams J, Balzer-Geldsetzer M, Hilker-Roggendorf R, Oberschmidt C, Baudrexel S, Witt K, Schmidt N, Deuschl G, Mollenhauer B, Trenkwalder C, Liepelt-Scarfone I, Spottke A, Roeske S, Wüllner U, Wittchen HU, Riedel O, Dodel R, Schulz JB, Reetz K.

J Neurol Neurosurg Psychiatry. 2019 Feb;90(2):171-179. doi: 10.1136/jnnp-2018-319008. Epub 2018 Oct 8.

PMID:
30297519
5.

T1 mapping with the variable flip angle technique: A simple correction for insufficient spoiling of transverse magnetization.

Baudrexel S, Nöth U, Schüre JR, Deichmann R.

Magn Reson Med. 2018 Jun;79(6):3082-3092. doi: 10.1002/mrm.26979. Epub 2017 Oct 20.

PMID:
29052267
6.

Psychometric properties of the apathy evaluation scale in patients with Parkinson's disease.

Lueken U, Evens R, Balzer-Geldsetzer M, Baudrexel S, Dodel R, Gräber-Sultan S, Hilker-Roggendorf R, Kalbe E, Kaut O, Mollenhauer B, Reetz K, Schäffer E, Schmidt N, Schulz JB, Spottke A, Witt K, Linse K, Storch A, Riedel O.

Int J Methods Psychiatr Res. 2017 Dec;26(4). doi: 10.1002/mpr.1564. Epub 2017 Apr 18.

PMID:
28418163
7.

Longitudinal changes of cortical microstructure in Parkinson's disease assessed with T1 relaxometry.

Nürnberger L, Gracien RM, Hok P, Hof SM, Rüb U, Steinmetz H, Hilker R, Klein JC, Deichmann R, Baudrexel S.

Neuroimage Clin. 2016 Dec 21;13:405-414. doi: 10.1016/j.nicl.2016.12.025. eCollection 2017.

8.

Evaluation of brain ageing: a quantitative longitudinal MRI study over 7 years.

Gracien RM, Nürnberger L, Hok P, Hof SM, Reitz SC, Rüb U, Steinmetz H, Hilker-Roggendorf R, Klein JC, Deichmann R, Baudrexel S.

Eur Radiol. 2017 Apr;27(4):1568-1576. doi: 10.1007/s00330-016-4485-1. Epub 2016 Jul 5.

PMID:
27379992
9.

Apolipoprotein E ε4 does not affect cognitive performance in patients with Parkinson's disease.

Mengel D, Dams J, Ziemek J, Becker J, Balzer-Geldsetzer M, Hilker R, Baudrexel S, Kalbe E, Schmidt N, Witt K, Liepelt-Scarfone I, Gräber S, Petrelli A, Neuser P, Schulte C, Linse K, Storch A, Wittchen HU, Riedel O, Mollenhauer B, Ebentheuer J, Trenkwalder C, Klockgether T, Spottke A, Wüllner U, Schulz JB, Reetz K, Heber IA, Ramirez A, Dodel R.

Parkinsonism Relat Disord. 2016 Aug;29:112-6. doi: 10.1016/j.parkreldis.2016.04.013. Epub 2016 Apr 19.

PMID:
27321987
10.

Verbal memory declines more in female patients with Parkinson's disease: the importance of gender-corrected normative data.

Fengler S, Roeske S, Heber I, Reetz K, Schulz JB, Riedel O, Wittchen HU, Storch A, Linse K, Baudrexel S, Hilker R, Mollenhauer B, Witt K, Schmidt N, Balzer-Geldsetzer M, Dams J, Dodel R, Gräber S, Pilotto A, Petrelli A, Fünkele S, Kassubek J, Kalbe E.

Psychol Med. 2016 Aug;46(11):2275-86. doi: 10.1017/S0033291716000908. Epub 2016 May 19.

PMID:
27193073
11.

Quantitative T1 and proton density mapping with direct calculation of radiofrequency coil transmit and receive profiles from two-point variable flip angle data.

Baudrexel S, Reitz SC, Hof S, Gracien RM, Fleischer V, Zimmermann H, Droby A, Klein JC, Deichmann R.

NMR Biomed. 2016 Mar;29(3):349-60. doi: 10.1002/nbm.3460. Epub 2016 Jan 12.

PMID:
26756673
12.

Ultrasound-based motion analysis demonstrates bilateral arm hypokinesia during gait in heterozygous PINK1 mutation carriers.

Nürnberger L, Klein C, Baudrexel S, Roggendorf J, Hildner M, Chen S, Kang JS, Hilker R, Hagenah J.

Mov Disord. 2015 Mar;30(3):386-92. doi: 10.1002/mds.26127. Epub 2014 Dec 27.

PMID:
25545816
13.

Investigating the human brainstem with structural and functional MRI.

Beissner F, Baudrexel S.

Front Hum Neurosci. 2014 Feb 28;8:116. doi: 10.3389/fnhum.2014.00116. eCollection 2014. No abstract available.

14.

White matter damage is related to ataxia severity in SCA3.

Kang JS, Klein JC, Baudrexel S, Deichmann R, Nolte D, Hilker R.

J Neurol. 2014 Feb;261(2):291-9. doi: 10.1007/s00415-013-7186-6. Epub 2013 Nov 23.

PMID:
24272589
15.

The value of putaminal diffusion imaging versus 18-fluorodeoxyglucose positron emission tomography for the differential diagnosis of the Parkinson variant of multiple system atrophy.

Baudrexel S, Seifried C, Penndorf B, Klein JC, Middendorp M, Steinmetz H, Grünwald F, Hilker R.

Mov Disord. 2014 Mar;29(3):380-7. doi: 10.1002/mds.25749. Epub 2013 Nov 15.

PMID:
24243813
16.

The bioenergetic status relates to dopamine neuron loss in familial PD with PINK1 mutations.

Hilker R, Pilatus U, Eggers C, Hagenah J, Roggendorf J, Baudrexel S, Klein JC, Neumaier B, Fink GR, Steinmetz H, Klein C, Hattingen E.

PLoS One. 2012;7(12):e51308. doi: 10.1371/journal.pone.0051308. Epub 2012 Dec 10.

17.

Diurnal variation of hypothalamic function and chronic subthalamic nucleus stimulation in Parkinson's disease.

Seifried C, Boehncke S, Heinzmann J, Baudrexel S, Weise L, Gasser T, Eggert K, Fogel W, Baas H, Badenhoop K, Steinmetz H, Hilker R.

Neuroendocrinology. 2013;97(3):283-90. doi: 10.1159/000343808. Epub 2012 Nov 22.

PMID:
23051911
18.

Relation of brain stimulation induced changes in MEP amplitude and BOLD signal.

Kriváneková L, Baudrexel S, Bliem B, Ziemann U.

Brain Stimul. 2013 May;6(3):330-9. doi: 10.1016/j.brs.2012.06.004. Epub 2012 Jul 2.

PMID:
22770886
19.

GBA-associated PD. Neurodegeneration, altered membrane metabolism, and lack of energy failure.

Brockmann K, Hilker R, Pilatus U, Baudrexel S, Srulijes K, Magerkurth J, Hauser AK, Schulte C, Csoti I, Merten CD, Gasser T, Berg D, Hattingen E.

Neurology. 2012 Jul 17;79(3):213-20. doi: 10.1212/WNL.0b013e31825dd369. Epub 2012 Jun 20.

PMID:
22722629
20.

The tremor network targeted by successful VIM deep brain stimulation in humans.

Klein JC, Barbe MT, Seifried C, Baudrexel S, Runge M, Maarouf M, Gasser T, Hattingen E, Liebig T, Deichmann R, Timmermann L, Weise L, Hilker R.

Neurology. 2012 Mar 13;78(11):787-95. doi: 10.1212/WNL.0b013e318249f702. Epub 2012 Feb 29.

PMID:
22377809
21.

Arm swing asymmetry in Parkinson's disease measured with ultrasound based motion analysis during treadmill gait.

Roggendorf J, Chen S, Baudrexel S, van de Loo S, Seifried C, Hilker R.

Gait Posture. 2012 Jan;35(1):116-20. doi: 10.1016/j.gaitpost.2011.08.020. Epub 2011 Sep 29.

PMID:
21962405
22.

Intraoperative microelectrode recording for the delineation of subthalamic nucleus topography in Parkinson's disease.

Seifried C, Weise L, Hartmann R, Gasser T, Baudrexel S, Szelényi A, van de Loo S, Steinmetz H, Seifert V, Roeper J, Hilker R.

Brain Stimul. 2012 Jul;5(3):378-387. doi: 10.1016/j.brs.2011.06.002. Epub 2011 Jul 8.

PMID:
21782543
23.

fMRI of the brainstem using dual-echo EPI.

Beissner F, Deichmann R, Baudrexel S.

Neuroimage. 2011 Apr 15;55(4):1593-9. doi: 10.1016/j.neuroimage.2011.01.042. Epub 2011 Jan 20.

PMID:
21256220
24.

Resting state fMRI reveals increased subthalamic nucleus-motor cortex connectivity in Parkinson's disease.

Baudrexel S, Witte T, Seifried C, von Wegner F, Beissner F, Klein JC, Steinmetz H, Deichmann R, Roeper J, Hilker R.

Neuroimage. 2011 Apr 15;55(4):1728-38. doi: 10.1016/j.neuroimage.2011.01.017. Epub 2011 Jan 19.

PMID:
21255661
25.

[Innovative MRI techniques in Parkinson's disease].

Baudrexel S, Klein JC, Deichmann R, Hilker R.

Nervenarzt. 2010 Oct;81(10):1180-8. doi: 10.1007/s00115-010-3023-7. Review. German.

PMID:
20798918
26.

Diffusion tensor imaging of white matter involvement in essential tremor.

Klein JC, Lorenz B, Kang JS, Baudrexel S, Seifried C, van de Loo S, Steinmetz H, Deichmann R, Hilker R.

Hum Brain Mapp. 2011 Jun;32(6):896-904. doi: 10.1002/hbm.21077. Epub 2010 Jun 22.

PMID:
20572209
27.

Dual-echo EPI for non-equilibrium fMRI - implications of different echo combinations and masking procedures.

Beissner F, Baudrexel S, Volz S, Deichmann R.

Neuroimage. 2010 Aug 15;52(2):524-31. doi: 10.1016/j.neuroimage.2010.04.243. Epub 2010 Apr 24.

PMID:
20420927
28.

Quantitative mapping of T1 and T2* discloses nigral and brainstem pathology in early Parkinson's disease.

Baudrexel S, Nürnberger L, Rüb U, Seifried C, Klein JC, Deller T, Steinmetz H, Deichmann R, Hilker R.

Neuroimage. 2010 Jun;51(2):512-20. doi: 10.1016/j.neuroimage.2010.03.005. Epub 2010 Mar 6.

PMID:
20211271
29.

Neurotransmitter changes in dementia with Lewy bodies and Parkinson disease dementia in vivo.

Klein JC, Eggers C, Kalbe E, Weisenbach S, Hohmann C, Vollmar S, Baudrexel S, Diederich NJ, Heiss WD, Hilker R.

Neurology. 2010 Mar 16;74(11):885-92. doi: 10.1212/WNL.0b013e3181d55f61. Epub 2010 Feb 24.

PMID:
20181924
30.

Rapid single-scan T2*-mapping using exponential excitation pulses and image-based correction for linear background gradients.

Baudrexel S, Volz S, Preibisch C, Klein JC, Steinmetz H, Hilker R, Deichmann R.

Magn Reson Med. 2009 Jul;62(1):263-8. doi: 10.1002/mrm.21971.

31.

Frontal FDG-PET activity correlates with cognitive outcome after STN-DBS in Parkinson disease.

Kalbe E, Voges J, Weber T, Haarer M, Baudrexel S, Klein JC, Kessler J, Sturm V, Heiss WD, Hilker R.

Neurology. 2009 Jan 6;72(1):42-9. doi: 10.1212/01.wnl.0000338536.31388.f0.

PMID:
19122029
32.

Measuring sub-millisecond delays in spiking activity with millisecond time-bins.

Havenith MN, Zemmar A, Yu S, Baudrexel SM, Singer W, Nikolić D.

Neurosci Lett. 2009 Feb 6;450(3):296-300. doi: 10.1016/j.neulet.2008.11.066. Epub 2008 Dec 6.

PMID:
19070651
33.

Neural traffic as voxel-based measure of cerebral functional connectivity in fMRI.

Beu M, Baudrexel S, Hautzel H, Antke C, Mueller HW.

J Neurosci Methods. 2009 Jan 30;176(2):263-9. doi: 10.1016/j.jneumeth.2008.08.036. Epub 2008 Sep 12.

PMID:
18834906
34.

STN-DBS activates the target area in Parkinson disease: an FDG-PET study.

Hilker R, Voges J, Weber T, Kracht LW, Roggendorf J, Baudrexel S, Hoevels M, Sturm V, Heiss WD.

Neurology. 2008 Sep 2;71(10):708-13. doi: 10.1212/01.wnl.0000312380.01852.77. Epub 2008 Jul 23.

PMID:
18650492
35.

Introduction of helical computed tomography affects patient selection for V/Q lung scan.

Zettinig G, Baudrexel S, Leitha T.

Nuklearmedizin. 2002 Apr;41(2):91-4.

PMID:
11989303

Supplemental Content

Loading ...
Support Center